Stay updated on Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRecruitment status now shows 'No longer looking for participants', and new user guidance sections have been added: 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The labeling for interventions is updated to 'Intervention/Treatment' and the page includes a revision note 'Revision: v3.6.0'.SummaryDifference0.4%

- Check19 days agoChange DetectedVersion updated from v3.5.4 to v3.5.5, signaling a minor revision of the site's underlying code or assets. There are no apparent changes to the page content or user-facing features based on the provided changes.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision tag, Revision: v3.5.4, was added and the previous tag Revision: v3.5.3 was removed. This indicates a minor update to the page's revision history rather than a substantive content change.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now displays an updated ClinicalTrials.gov release/version identifier (“Revision: v3.5.3”) instead of the previous one (“v3.5.2”), with no other study-details text change shown.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the page header.SummaryDifference0.1%

Stay in the know with updates to Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.